Cybin

HELPNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$849.802 M

$13.71 +0.37%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#169InventivaIVA$862.4M
#170Wave Life SciencesWVE$857.2M
#171CybinHELP$849.8M
#172Olema PharmaceuticalsOLMA$843.5M
#173Aclaris TherapeuticsACRS$842.0M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Cybin, worth $1.35M. Grants and option exercises are excluded.

Michael HalsteadChief Executive Officer$1.35M
100,000 shares at $13.47 on 21 Sept 2026 · filed 21 Sept 2026

What if Cybin were worth as much as…

Open the what-if tool →

Gold $30.2T

$487,769.94

Per share 35,578× higher

Bitcoin $1.74T

$28,098.43

Per share 2,049× higher

Nvidia $5.52T

$88,986.84

Per share 6,491× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Cybin are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.